怡園酒業(08146.HK)年度盈轉虧至56.2萬元
格隆匯 3 月 19日丨怡園酒業(08146.HK)發佈公吿,截至2020年12月31日止年度,實現收益6022.4萬元人民幣(單位下同),同比減少17.17%;期內溢利及公司擁有人應占淨虧56.2萬元,去年則溢利3萬元,盈轉虧;基本及攤薄每股淨虧0.07分。
就集團財務表現而言,2020年全年的毛利下跌10.6%,主要由於新冠肺炎疫情影響使銷售活動停滯,導致葡萄酒第一季銷售下降。
於疫情期間,國內的羣體性聚餐大幅減少,葡萄酒的消費急速下降,曾為集團短期業績帶來負面影響。隨着疫情漸趨穩定,葡萄酒的銷售情況顯著好轉。加上憑着集團積極的銷售策略,集團於下半年的銷售業績有所改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.